Abstract
The incidence of nausea and vomiting affects 25-30% of individuals after surgery and in high-risk patients, this incidence can reach 70-80%. The identification of individuals at high risk for postoperative nausea and vomiting (PONV) may restrict the number of potential candidates for a particular type of anti-emetic therapy, indicating those most likely to benefit from the effect of certa…